These results argue in favor of the acquisition of PD-1 and CD39 expression by tumor-Ag-specific CD4 T cells in lymph nodes through chronic stimulation in the context of cancer, leading to the circulating PD-1+CD39+ memory CD4 T-cell population. The gene discussed is ENTPD1; the disease is neoplasm.